CYP cynata therapeutics limited

Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-57

  1. 9,103 Posts.
    lightbulb Created with Sketch. 7857
    Per the ASX announcement, the company will be presenting these initial srGVHD results at the forthcoming ISCT annual meeting:

    https://hotcopper.com.au/data/attachments/5311/5311839-b252d94d29525a384931b59d9c2253a4.jpg


    Mesoblast has itself presented both COVID and heart results itself at former ISCT annual meetings and conferences.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
0.000(0.00%)
Mkt cap ! $36.15M
Open High Low Value Volume
16.0¢ 16.5¢ 16.0¢ $53.16K 331.2K

Buyers (Bids)

No. Vol. Price($)
2 58274 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 4405 2
View Market Depth
Last trade - 14.11pm 25/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.